EDAP TMS is a medical distribution business based in the US. EDAP TMS shares (EDAP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.49 – an increase of 1.63% over the previous week. EDAP TMS employs 307 staff and has a trailing 12-month revenue of around $63.4 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $2.49 |
|---|---|
| 52-week range | $2.27 - $8.50 |
| 50-day moving average | $2.81 |
| 200-day moving average | $5.17 |
| Wall St. target price | $10.67 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.62 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.45 from 2024-11-20
| 1 week (2024-11-14) | -2.78% |
|---|---|
| 1 month (2024-10-21) | -11.23% |
| 3 months (2024-08-21) | -41.67% |
| 6 months (2024-05-21) | -59.23% |
| 1 year (2023-11-21) | -44.94% |
|---|---|
| 2 years (2022-11-21) | -76.56% |
| 3 years (2021-11-19) | 5.38 |
| 5 years (2019-11-21) | 4.62 |
Valuing EDAP TMS stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of EDAP TMS's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
EDAP TMS's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 90.47. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into EDAP TMS's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $63.4 million |
|---|---|
| Gross profit TTM | $24.2 million |
| Return on assets TTM | -12.24% |
| Return on equity TTM | -43.07% |
| Profit margin | -34.88% |
| Book value | $1.15 |
| Market Capitalization | $93.5 million |
TTM: trailing 12 months
We're not expecting EDAP TMS to pay a dividend over the next 12 months.
Over the last 12 months, EDAP TMS's shares have ranged in value from as little as $2.27 up to $8.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while EDAP TMS's is 0.38. This would suggest that EDAP TMS's shares are less volatile than average (for this exchange).
EDAP TMS S. A. , together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter, as well as sells disposable parts for lithotripters and electrodes.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.